Humoral immune responses in CD40 ligand-deficient mice. 1994

B R Renshaw, and W C Fanslow, and R J Armitage, and K A Campbell, and D Liggitt, and B Wright, and B L Davison, and C R Maliszewski
Department of Molecular Immunology, Immunex Research and Development Corporation, Seattle, Washington 98101.

Individuals with X-linked hyper-IgM syndrome fail to express functional CD40 ligand (CD40L) and, as a consequence, are incapable of mounting protective antibody responses to opportunistic bacterial infections. To address the role of CD40L in humoral immunity, we created, through homologous recombination, mice deficient in CD40L expression. These mice exhibited no gross developmental deficiencies or health abnormalities and contained normal percentages of B and T cell subpopulations. CD40L-deficient mice did display selective deficiencies in humoral immunity; basal serum isotype levels were significantly lower than observed in normal mice, and IgE was undetectable. Furthermore, the CD40L-deficient mice failed to mount secondary antigen-specific responses to immunization with a thymus-dependent antigen, trinitrophenol-conjugated keyhole limpet hemocyanin (TNP-KLH). By contrast, the CD40L-deficient mice produced antigen-specific antibody of all isotypes except IgE in response to the thymus-independent antigen, DNP-Ficoll. These results underscore the requirement of CD40L for T cell-dependent antibody responses. Moreover, Ig class switching to isotypes other than IgE can occur in vivo in the absence of CD40L, supporting the notion that alternative B cell signaling pathways regulate responses to thymus-independent antigens.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007132 Immunoglobulin Isotypes The classes of immunoglobulins found in any species of animal. In man there are nine classes that migrate in five different groups in electrophoresis; they each consist of two light and two heavy protein chains, and each group has distinguishing structural and functional properties. Antibody Class,Ig Isotype,Ig Isotypes,Immunoglobulin Class,Immunoglobulin Isotype,Antibody Classes,Immunoglobulin Classes,Class, Antibody,Class, Immunoglobulin,Classes, Antibody,Classes, Immunoglobulin,Isotype, Ig,Isotype, Immunoglobulin,Isotypes, Ig,Isotypes, Immunoglobulin
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008297 Male Males
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females

Related Publications

B R Renshaw, and W C Fanslow, and R J Armitage, and K A Campbell, and D Liggitt, and B Wright, and B L Davison, and C R Maliszewski
February 1998, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
B R Renshaw, and W C Fanslow, and R J Armitage, and K A Campbell, and D Liggitt, and B Wright, and B L Davison, and C R Maliszewski
December 1996, Journal of immunology (Baltimore, Md. : 1950),
B R Renshaw, and W C Fanslow, and R J Armitage, and K A Campbell, and D Liggitt, and B Wright, and B L Davison, and C R Maliszewski
August 2008, Journal of leukocyte biology,
B R Renshaw, and W C Fanslow, and R J Armitage, and K A Campbell, and D Liggitt, and B Wright, and B L Davison, and C R Maliszewski
July 2002, Transplantation,
B R Renshaw, and W C Fanslow, and R J Armitage, and K A Campbell, and D Liggitt, and B Wright, and B L Davison, and C R Maliszewski
August 1994, Immunity,
B R Renshaw, and W C Fanslow, and R J Armitage, and K A Campbell, and D Liggitt, and B Wright, and B L Davison, and C R Maliszewski
August 2011, Nagoya journal of medical science,
B R Renshaw, and W C Fanslow, and R J Armitage, and K A Campbell, and D Liggitt, and B Wright, and B L Davison, and C R Maliszewski
July 2003, Clinical and experimental immunology,
B R Renshaw, and W C Fanslow, and R J Armitage, and K A Campbell, and D Liggitt, and B Wright, and B L Davison, and C R Maliszewski
June 1994, Immunity,
B R Renshaw, and W C Fanslow, and R J Armitage, and K A Campbell, and D Liggitt, and B Wright, and B L Davison, and C R Maliszewski
May 2004, EMBO reports,
B R Renshaw, and W C Fanslow, and R J Armitage, and K A Campbell, and D Liggitt, and B Wright, and B L Davison, and C R Maliszewski
January 1996, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!